Probiotic Lactobacillus Plantarum 299v decreases kynurenine concentration and improves cognitive functions in patients with major depression: A double-blind, randomized, placebo controlled study

Psychoneuroendocrinology

Volumn 100, Issue , 2019, Pages 213-222

  Rudzki, Leszek ^a   Ostrowska, Lucyna ^a   Pawlak, Dariusz ^a   Małus, Aleksandra ^a   Pawlak, Krystyna ^a   Waszkiewicz, Napoleon ^a   Szulc, Agata ^b  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Cortisol; Cytokines; Gut brain axis; IL 1b; IL 6; Kynurenine; Kynurenine pathway; Lactobacillus Plantarum 299v; Major depression; Microbiota; Microbiota gut brain axis; Placebo controlled trial; Probiotic; Psychobiotic; TNF alpha

Indexed keywords

3 HYDROXYANTHRANILIC ACID; 3 HYDROXYKYNURENINE; ANTHRANILIC ACID; ESCITALOPRAM; FLUOXETINE; HYDROCORTISONE; INTERLEUKIN 1BETA; INTERLEUKIN 6; KYNURENIC ACID; KYNURENINE; PAROXETINE; PROBIOTIC AGENT; SERTRALINE; TRYPTOPHAN; TUMOR NECROSIS FACTOR; PLACEBO; SEROTONIN UPTAKE INHIBITOR;

ADULT; ARTICLE; ATTENTION AND PERCEPTIVITY TEST; BIOCHEMISTRY; CALIFORNIA VERBAL LEARNING TEST; COGNITION; COGNITIVE FUNCTION TEST; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; FEMALE; FIGURAL FLUENCY TEST; HAMILTON DEPRESSION RATING SCALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; IMMUNOMODULATION; LACTOBACILLUS PLANTARUM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PERCEIVED STRESS SCALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; STROOP TEST; SYMPTOM CHECKLIST 90; TRAIL MAKING TEST; TREATMENT DURATION; ATTENTION; BLOOD; DOWN REGULATION; DRUG EFFECT; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PHYSIOLOGY; PSYCHOLOGY; TREATMENT OUTCOME;

ADULT; ATTENTION; COGNITION; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DOUBLE-BLIND METHOD; DOWN-REGULATION; FEMALE; HUMANS; KYNURENINE; LACTOBACILLUS PLANTARUM; MALE; MIDDLE AGED; PLACEBOS; PROBIOTICS; SEROTONIN UPTAKE INHIBITORS; TREATMENT OUTCOME;

EID: 85055351010     PISSN: 03064530     EISSN: 18733360     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2018.10.010     Document Type: Article

References (47)

1. Akbari, E., Asemi, Z., Daneshvar Kakhaki, R., Bahmani, F., Kouchaki, E., Tamtaji, O.R., Hamidi, G.A., Salami, M., Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial. Front. Aging Neurosci., 2016, 8.
2. Akkasheh, G., Kashani-Poor, Z., Tajabadi-Ebrahimi, M., Jafari, P., Akbari, H., Taghizadeh, M., Memarzadeh, M.R., Asemi, Z., Esmaillzadeh, A., Clinical and metabolic response to probiotic administration in patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial. Nutrition 32 (2016), 315–320.
3. Cryan, J.F., Dinan, T.G., Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour. Nature reviews. Neuroscience 13 (2012), 701–712.
4. Deguchi, Y., Morishita, T., Mutai, M., Comparative Studies on Synthesis of Water-soluble Vitamins among Human Species of Bifidobacteria. Agric. Biol. Chem. 49 (2014), 13–19.
5. Desbonnet, L., Garrett, L., Clarke, G., Kiely, B., Cryan, J.F., Dinan, T.G., Effects of the probiotic Bifidobacterium infantis in the maternal separation model of depression. Neuroscience 170 (2010), 1179–1188.
6. Ducrotte, P., Sawant, P., Jayanthi, V., Clinical trial: Lactobacillus plantarum 299v (DSM 9843) improves symptoms of irritable bowel syndrome. World J. Gastroenterol. 18 (2012), 4012–4018.
7. Esnafoglu, E., Cirrik, S., Ayyildiz, S.N., Erdil, A., Erturk, E.Y., Dagli, A., Noyan, T., Increased Serum Zonulin Levels as an Intestinal Permeability Marker in Autistic Subjects. J. Pediatr. 188 (2017), 240–244.
8. Ferrier, L., Significance of increased human colonic permeability in response to corticotrophin-releasing hormone (CRH). Gut 57 (2008), 7–9.
9. Freewan, M., Rees, M.D., Plaza, T.S., Glaros, E., Lim, Y.J., Wang, X.S., Yeung, A.W., Witting, P.K., Terentis, A.C., Thomas, S.R., Human indoleamine 2,3-dioxygenase is a catalyst of physiological heme peroxidase reactions: implications for the inhibition of dioxygenase activity by hydrogen peroxide. J. Biol. Chem. 288 (2013), 1548–1567.
10. Gareau, M.G., Microbiota-gut-brain axis and cognitive function. Adv. Exp. Med. Biol. 817 (2014), 357–371.
11. Gareau, M.G., Jury, J., MacQueen, G., Sherman, P.M., Perdue, M.H., Probiotic treatment of rat pups normalises corticosterone release and ameliorates colonic dysfunction induced by maternal separation. Gut 56 (2007), 1522–1528.
12. Gu, Q., Li, P., Biosynthesis of vitamins by probiotic bacteria. Rao, V., Rao, L.G., (eds.) Probiotics and Prebiotics in Human Nutrition and Health, 2016, InTech, Rijeka p. Ch. 07.
13. Hankes, L.V., Leklem, J.E., Brown, R.R., Mekel, R.C., Tryptophan metabolism in patients with pellagra: problem of vitamin B 6 enzyme activity and feedback control of tryptophan pyrrolase enzyme. Am. J. Clin. Nutr. 24 (1971), 730–739.
14. Herve, C., Beyne, P., Jamault, H., Delacoux, E., Determination of tryptophan and its kynurenine pathway metabolites in human serum by high-performance liquid chromatography with simultaneous ultraviolet and fluorimetric detection. Journal of chromatography. B, Biomedical applications 675 (1996), 157–161.
15. Hill, M.J., Intestinal flora and endogenous vitamin synthesis. Eur. J. Cancer Prevent., 6(Suppl. 1), 1997 S43-45.
16. Holmes, E.W., Determination of serum kynurenine and hepatic tryptophan dioxygenase activity by high-performance liquid chromatography. Anal. Biochem. 172 (1988), 518–525.
17. Huang, R., Wang, K., Hu, J., Effect of probiotics on depression: a systematic review and meta-analysis of randomized controlled trials. Nutrients, 2016, 8.
18. Jaworski, M., Artykuł poglądowyNeuropsychologiczne aspekty zaburzenia procesów uwagi w przebiegu jadłowstrętu psychicznego. Neuropsychiatria i Neuropsychologia/Neuropsychiatry and Neuropsychology 9 (2014), 30–37.
19. Johansson, M.L., Nobaek, S., Berggren, A., Nyman, M., Björck, I., Ahrné S., Jeppsson, B., Molin, G., Survival of Lactobacillus plantarum DSM 9843 (299v), and effect on the short-chain fatty acid content of faeces after ingestion of a rose-hip drink with fermented oats. Int. J. Food Microbiol. 42 (1998), 29–38.
20. Klarin, B., Johansson, M.-L., Molin, G., Larsson, A., Jeppsson, B., Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial. Crit. Care 9 (2005), R285–R293.
21. Leclercq, S., Matamoros, S., Cani, P.D., Neyrinck, A.M., Jamar, F., Starkel, P., Windey, K., Tremaroli, V., Backhed, F., Verbeke, K., de Timary, P., Delzenne, N.M., Intestinal permeability, gut-bacterial dysbiosis, and behavioral markers of alcohol-dependence severity. Proc. Natl. Acad. Sci. U. S. A. 111 (2014), E4485–4493.
22. Leklem, J.E., Quantitative aspects of tryptophan metabolism in humans and other species: a review. Am. J. Clin. Nutr. 24 (1971), 659–672.
23. Maes, M., Kubera, M., Leunis, J.C., The gut-brain barrier in major depression: intestinal mucosal dysfunction with an increased translocation of LPS from gram negative enterobacteria (leaky gut) plays a role in the inflammatory pathophysiology of depression. Neuro Endocrinol. Lett. 29 (2008), 117–124.
24. Maes, M., Kubera, M., Leunis, J.C., Berk, M., Increased IgA and IgM responses against gut commensals in chronic depression: further evidence for increased bacterial translocation or leaky gut. J. Affect. Disord. 141 (2012), 55–62.
25. Maes, M., Leonard, B.E., Myint, A.M., Kubera, M., Verkerk, R., The new’ 5-HT’ hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 35 (2011), 702–721.
26. Maes, M., Leunis, J.C., Normalization of leaky gut in chronic fatigue syndrome (CFS) is accompanied by a clinical improvement: effects of age, duration of illness and the translocation of LPS from gram-negative bacteria. Neuro Endocrinol. Lett. 29 (2008), 902–910.
27. Mangell, P., Nejdfors, P., Wang, M., Ahrne, S., Westrom, B., Thorlacius, H., Jeppsson, B., Lactobacillus plantarum 299v inhibits Escherichia coli-induced intestinal permeability. Dig. Dis. Sci. 47 (2002), 511–516.
28. Murphy, M.G., Condon, S., Correlation of oxygen utilization and hydrogen peroxide accumulation with oxygen induced enzymes in Lactobacillus plantarum cultures. Arch. Microbiol. 138 (1984), 44–48.
29. O'Mahony, S.M., Clarke, G., Borre, Y.E., Dinan, T.G., Cryan, J.F., Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav. Brain Res. 277 (2015), 32–48.
30. Oxenkrug, G., Ratner, R., Summergrad, P., Kynurenines and vitamin B6: link between diabetes and depression. J. Bioinform. Diabetes, 1, 2013 http://openaccesspub.org/journals/download.php?file=51-OAP-JBD-IssuePDF.pdf.
31. Paul, L., Ueland, P.M., Selhub, J., Mechanistic perspective on the relationship between pyridoxal 5’-phosphate and inflammation. Nutr. Rev. 71 (2013), 239–244.
32. Rao, A.V., Bested, A.C., Beaulne, T.M., Katzman, M.A., Iorio, C., Berardi, J.M., Logan, A.C., A randomized, double-blind, placebo-controlled pilot study of a probiotic in emotional symptoms of chronic fatigue syndrome. Gut Pathog., 1, 2009, 6.
33. Schultz, M., Veltkamp, C., Dieleman, L.A., Grenther, W.B., Wyrick, P.B., Tonkonogy, S.L., Sartor, R.B., Lactobacillus plantarum 299V in the treatment and prevention of spontaneous colitis in interleukin-10-deficient mice. Inflamm. Bowel Dis. 8 (2002), 71–80.
34. Schwarcz, R., Bruno, J.P., Muchowski, P.J., Wu, H.Q., Kynurenines in the mammalian brain: when physiology meets pathology. Nature reviews. Neuroscience 13 (2012), 465–477.
35. Schwarcz, R., Rassoulpour, A., Wu, H.Q., Medoff, D., Tamminga, C.A., Roberts, R.C., Increased cortical kynurenate content in schizophrenia. Biol. Psychiatry 50 (2001), 521–530.
36. Severance, E.G., Alaedini, A., Yang, S., Halling, M., Gressitt, K.L., Stallings, C.R., Origoni, A.E., Vaughan, C., Khushalani, S., Leweke, F.M., Dickerson, F.B., Yolken, R.H., Gastrointestinal inflammation and associated immune activation in schizophrenia. Schizophr. Res. 138 (2012), 48–53.
37. Severance, E.G., Dupont, D., Dickerson, F.B., Stallings, C.R., Origoni, A.E., Krivogorsky, B., Yang, S., Haasnoot, W., Yolken, R.H., Immune activation by casein dietary antigens in bipolar disorder. Bipolar Disord. 12 (2010), 834–842.
38. Steiner, J., Walter, M., Gos, T., Guillemin, G.J., Bernstein, H.-G., Sarnyai, Z., Mawrin, C., Brisch, R., Bielau, H., zu Schwabedissen, L.M., Bogerts, B., Myint, A.-M., Severe depression is associated with increased microglial quinolinic acid in subregions of the anterior cingulate gyrus: Evidence for an immune-modulated glutamatergic neurotransmission?. J. Neuroinflamm., 8, 2011, 94.
39. Stone, T.W., Darlington, L.G., The kynurenine pathway as a therapeutic target in cognitive and neurodegenerative disorders. Br. J. Pharmacol. 169 (2013), 1211–1227.
40. Thakur, K., Tomar, S.K., De, S., Lactic acid bacteria as a cell factory for riboflavin production. Microb. Biotechnol. 9 (2016), 441–451.
41. Theofylaktopoulou, D., Ulvik, A., Midttun, O., Ueland, P.M., Vollset, S.E., Nygard, O., Hustad, S., Tell, G.S., Eussen, S.J., Vitamins B2 and B6 as determinants of kynurenines and related markers of interferon-gamma-mediated immune activation in the community-based Hordaland Health Study. Br. J. Nutr. 112 (2014), 1065–1072.
42. Ueland, P.M., McCann, A., Midttun, O., Ulvik, A., Inflammation, vitamin B6 and related pathways. Mol. Aspects Med. 53 (2017), 10–27.
43. Valladares, R., Bojilova, L., Potts, A.H., Cameron, E., Gardner, C., Lorca, G., Gonzalez, C.F., Lactobacillus johnsonii inhibits indoleamine 2,3-dioxygenase and alters tryptophan metabolite levels in BioBreeding rats. FASEB J. 27 (2013), 1711–1720.
44. White, J.S., Hoper, M., Parks, R.W., Clements, W.D., Diamond, T., Bengmark, S., The probiotic bacterium Lactobacillus plantarum species 299 reduces intestinal permeability in experimental biliary obstruction. Lett. Appl. Microbiol. 42 (2006), 19–23.
45. Wichers, M.C., Koek, G.H., Robaeys, G., Verkerk, R., Scharpe, S., Maes, M., IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Mol. Psychiatry 10 (2005), 538–544.
46. Wonodi, I., Stine, O.C., Sathyasaikumar, K.V., Roberts, R.C., Mitchell, B.D., Hong, L.E., Kajii, Y., Thaker, G.K., Schwarcz, R., Downregulated kynurenine 3-monooxygenase gene expression and enzyme activity in schizophrenia and genetic association with schizophrenia endophenotypes. Arch. Gen. Psychiatry 68 (2011), 665–674.
47. Zareie, M., Johnson‐Henry, K., Jury, J., Yang, P.C., Ngan, B.Y., McKay, D.M., Soderholm, J.D., Perdue, M.H., Sherman, P.M., Probiotics prevent bacterial translocation and improve intestinal barrier function in rats following chronic psychological stress. Gut 55 (2006), 1553–1560.